Barbari Sharon Insider Trades

Insider Trading History

Track insider trading activity for Barbari Sharon. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
VYNE Therapeutics
VYNE Therapeutics VYNE
Director
Holding Value $13.3k 20,000 shares
Last Trade
Dec 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.6k 20,000 shares
$0.38
$0.67
VYNE Therapeutics
VYNE Therapeutics VYNE
Director
Holding Value $13.3k 20,000 shares
Last Trade
Dec 12, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$48k 20,000 shares
$2.40
$0.67
Agile Therapeutics
Agile Therapeutics AGRX
Director
Holding Value $0 0 shares
Last Trade
Aug 26, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.48k 973 shares
$1.52
$1.51
VYNE Therapeutics
VYNE Therapeutics VYNE
Director
Holding Value $13.3k 20,000 shares
Last Trade
Jan 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$46.6k 20,000 shares
$2.33
$0.67
VYNE Therapeutics
VYNE Therapeutics VYNE
Director
Holding Value $13.3k 20,000 shares
Last Trade
Dec 13, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$54k 20,000 shares
$2.70
$0.67
Agile Therapeutics
Agile Therapeutics AGRX
Director
Holding Value $1.61k 1,065 shares
Last Trade
Jun 08, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.81k 1,065 shares
$3.58
$1.51
VYNE Therapeutics
VYNE Therapeutics VYNE
Director
Holding Value $13.6k 20,500 shares
Last Trade
Aug 10, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.4k 20,500 shares
$0.31
$0.67
Menlo Therapeutics
Menlo Therapeutics MNLO
Director
Holding Value $0 20,500 shares
Last Trade
Aug 10, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.00
Agile Therapeutics
Agile Therapeutics AGRX
Director
Holding Value $2.95k 1,952 shares
Last Trade
Jun 09, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.04M 670 shares
$3,050.00
$1.51
VYNE Therapeutics
VYNE Therapeutics VYNE
Director
Holding Value $13.6k 20,500 shares
Last Trade
Jul 19, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$56.4k 20,500 shares
$2.75
$0.67
Agile Therapeutics
Agile Therapeutics AGRX
Director
Holding Value $77.5k 51,296 shares
Last Trade
Jun 08, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.58B 29,905 shares
$153,000.00
$1.51
VYNE Therapeutics
VYNE Therapeutics VYNE
Director
Holding Value $49.9k 75,000 shares
Last Trade
Aug 20, 2020 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$111k 75,000 shares
$1.48
$0.67
VYNE Therapeutics
VYNE Therapeutics VYNE
Director
Holding Value $9.29k 13,971 shares
Last Trade
Aug 20, 2020 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$111k 75,000 shares
$1.48
$0.67
Menlo Therapeutics
Menlo Therapeutics MNLO
Director
Holding Value $0 13,971 shares
Last Trade
Aug 20, 2020 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
No data
No data
$0.00
Menlo Therapeutics
Menlo Therapeutics MNLO
Director
Holding Value $0 75,000 shares
Last Trade
Aug 20, 2020 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
No data
No data
$0.00
Menlo Therapeutics
Menlo Therapeutics MNLO
Director
Holding Value $0 22,500 shares
Last Trade
Aug 03, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.00
VYNE Therapeutics
VYNE Therapeutics VYNE
Director
Holding Value $15k 22,500 shares
Last Trade
Aug 03, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$38.7k 22,500 shares
$1.72
$0.67
Agile Therapeutics
Agile Therapeutics AGRX
Director
Holding Value $68.3k 45,212 shares
Last Trade
Jun 09, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$12.7B 45,212 shares
$280,000.00
$1.51

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up